You are here

Meeting Highlights

Chemotherapy Foundation Symposium XXIV: Innovative Cancer Therapy for Tomorrow

Marvin M. Goldenberg, PhD, RPh, MS
PDF version: 
Standard and novel agents for various hematological malignancies include therapies for Hodgkin’s lymphoma, chronic lymphocytic leukemia, acute and chronic myelogenous leukemia, myelodysplastic syndromes, and multiple myeloma.